IND

(redirected from Investigational New Drug)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

IND

GOST 7.67 Latin three-letter geocode for India. The code is used for transactions to and from Indian bank accounts and for international shipping to India. As with all GOST 7.67 codes, it is used primarily in Cyrillic alphabets.
References in periodicals archive ?
United States-based Dicerna Pharmaceuticals has submitted an investigational new drug application to the US Food and Drug Administration for its DCR-PH1 therapeutic candidate, it was reported yesterday.
Dicerna Pharmaceuticals submits investigational new drug application to US FDA for DCR-PH1
Various statements in this release concerning our future expectations, plans, and prospects, including the timing for the filing of an investigational new drug application for, and statements regarding the development of, an RNAi therapeutic targeting PCSK9 for the treatment of hypercholesterolemia, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995.
Alnylam Advances a Systemically Delivered RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia as New Development Program
United States-based Valor Biotherapeutics has received approval for an investigational new drug application for its lead product candidate, IGN002, a new class of biotherapeutics, from the US Food and Drug Administration, it was reported yesterday.
Valor Biotherapeutics receives approval for investigational new drug application for IGN002
Altus Pharmaceuticals expects to file an investigational new drug (IND) application for ALTU-237 in the first half of 2007.
Altus Pharmaceuticals Reports Positive ALTU-237 Pre-Clinical Data for Reducing Hyperoxaluria, a Precusor to Kidney Stone Formation
M2 EQUITYBITES-August 4, 2015-Mundipharma EDO's investigational new drug for EDO-S101 accepted for review by US FDA
Mundipharma EDO's investigational new drug for EDO-S101 accepted for review by US FDA
SRI will perform medicinal chemistry, custom drug synthesis, formulation, analytical chemistry, clinical manufacturing, microbiology and virology screening, pharmacokinetics, safety testing, and preparation of Investigational New Drug (IND) applications to the U.
SRI International Awarded a Multimillion Dollar Contract from the National Institute of Allergy and Infectious Diseases
M2 PHARMA-July 15, 2015-The US FDA accepts Blueprint Medicines' investigational new drug application for Phase I clinical trials of BLU-554 and BLU-285
The US FDA accepts Blueprint Medicines' investigational new drug application for Phase I clinical trials of BLU-554 and BLU-285
M2 EQUITYBITES-July 15, 2015-The US FDA accepts Blueprint Medicines' investigational new drug application for Phase I clinical trials of BLU-554 and BLU-285
The US FDA accepts Blueprint Medicines' investigational new drug application for Phase I clinical trials of BLU-554 and BLU-285
M2 EQUITYBITES-March 31, 2015-China Food and Drug Administration agrees to review of WuXi MedImmune's investigational new drug application for new anti-IL6
China Food and Drug Administration agrees to review of WuXi MedImmune's investigational new drug application for new anti-IL6
M2 PHARMA-March 31, 2015-China Food and Drug Administration agrees to review of WuXi MedImmune's investigational new drug application for new anti-IL6
China Food and Drug Administration agrees to review of WuXi MedImmune's investigational new drug application for new anti-IL6
He has been involved in filing 11 Investigational New Drug (IND) Applications and 2 Biological License Applications (BLA).
Former Amgen Manufacturing Executive Joins Insmed
M2 EQUITYBITES-February 6, 2015-Sangamo BioSciences submits investigational new drug application for SB-BCLmR-HSPC to US FDA
Sangamo BioSciences submits investigational new drug application for SB-BCLmR-HSPC to US FDA
Financial browser ?
Full browser ?